We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos
FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos
January 25, 2013
An FDA advisory panel voted 19–10 Friday to recommend up-scheduling hydrocodone combination products to schedule II controlled substances, a move that would bring tighter restrictions on the opioid painkillers.